Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Capricor Therapeutics (CAPR) over the last 17 years, with Q3 2025 value amounting to $28.1 million.

  • Capricor Therapeutics' Total Current Liabilities rose 3747.28% to $28.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.1 million, marking a year-over-year increase of 3747.28%. This contributed to the annual value of $21.0 million for FY2024, which is 3275.89% down from last year.
  • Per Capricor Therapeutics' latest filing, its Total Current Liabilities stood at $28.1 million for Q3 2025, which was up 3747.28% from $28.4 million recorded in Q2 2025.
  • In the past 5 years, Capricor Therapeutics' Total Current Liabilities registered a high of $37.1 million during Q1 2023, and its lowest value of $3.0 million during Q3 2021.
  • For the 5-year period, Capricor Therapeutics' Total Current Liabilities averaged around $21.1 million, with its median value being $22.4 million (2024).
  • As far as peak fluctuations go, Capricor Therapeutics' Total Current Liabilities surged by 67617.93% in 2022, and later tumbled by 3781.47% in 2024.
  • Quarter analysis of 5 years shows Capricor Therapeutics' Total Current Liabilities stood at $4.1 million in 2021, then skyrocketed by 470.63% to $23.6 million in 2022, then surged by 32.57% to $31.3 million in 2023, then crashed by 32.76% to $21.0 million in 2024, then skyrocketed by 33.87% to $28.1 million in 2025.
  • Its Total Current Liabilities stands at $28.1 million for Q3 2025, versus $28.4 million for Q2 2025 and $22.3 million for Q1 2025.